Marico Limited, the maker of Parachute coconut oil, Saffola edible oils and a fast-scaling digital-first wellness portfolio, heads into its Q2 FY 2026-2027 print with an October 5 business update already signalling double-digit revenue growth and mid-twenties operating profit growth. The key things the results will speak to are the gross-margin bridge — copra roughly 35% below peak against inflationary crude-linked packaging inputs — and whether India volumes hold double digits after the 11% printed in Q1.
| Results date | November 02, 2026 |
|---|---|
| Quarter | Q2 FY 2026-2027 |
| Previous quarter revenue | Rs. 3,957 Cr |
| Previous quarter PAT | Rs. 630 Cr |
| Previous quarter EBITDA margin | 20.7% |
| Market cap | Rs. 100,115.69 Cr |
| CMP | Rs. 770.0 |
The Board of Directors is scheduled to meet on November 2, 2026, to consider the Q2 and H1 FY27 financial results. The trading window remained closed from September 26 to November 4, 2026.
Marico has intimated a Q2FY27 earnings call on November 2, 2026, at 6:00 p.m. IST. The speakers are Saugata Gupta (MD & CEO) and Pawan Agrawal (Group CFO & CEO – International Business).
At the AGM on August 6, 2026, shareholders approved a final dividend of Rs. 4 per equity share (face value Rs. 1) for FY26. This relates to the completed financial year and is separate from the Q2 FY27 results agenda.
The October 5 business update has pre-signalled a strong quarter — double-digit India volumes, double-digit consolidated revenue growth and operating profit growth in the mid-twenties — with management saying it is "likely to surpass near-term guidance across key financial parameters". The margin story is a mixed bridge: copra is roughly 35% below peak after a ~45% correction, supporting gross-margin expansion, but management itself flagged relatively higher input costs in Q2, with vegetable oils up ~20% over the year to mid-September and Brent up 24% in July, holding above $100 through September and keeping crude-linked LP and polymer derivatives (up 60–70% per the company) inflationary. The September 24 cut in edible-oil import duties — crude sunflower to nil, crude soybean/palm BCD from 10% to 5% — lands only in the final week of the quarter and reaches the P&L as higher-cost inventories are exhausted, making it mostly an H2 tailwind. On volumes, Parachute Coconut Oil accelerated to early-teens growth and Value Added Hair Oils posted a sixth consecutive quarter touching twenties, while Saffola Oils saw volumes decline on supply rationalisation of select variants; internationally, constant currency growth was in the teens led by Vietnam, Middle East and South Africa, with Bangladesh improving marginally sequentially after a 4% CCG in Q1. The Q2 base is demanding — Q2FY26 revenue grew 31% with about 2% GST-transition destocking — and the upcoming call is expected to cover whether the beat is framed as durable or timing, and whether FY27 aspirations are upgraded.
FY27 guidance scorecard: Status of the FY27 framework against the latest tracking signals:
Q2 beat magnitude and gross-margin bridge
Saffola volumes and Bangladesh recovery
PLIX stake increase and capital allocation
Risks and headwinds to monitor
Saffola Edible Oils saw a high single-digit volume decline in Q1FY27 as supply of select variants was rationalised to maintain threshold profitability, and volumes declined again in Q2 per the business update. An analyst has raised a medium-term volume question citing target-audience overlap with air-fryer adoption and GLP-1 usage; management's full response is not available in the retrieved excerpts.
Yes — MD & CEO Saugata Gupta has said "in fact, blended margin of foods could be higher" than the digital-first premium personal care target by FY30. Foods grew 43% in Q1FY27 and crossed a Rs. 1,300+ Cr annualised revenue run-rate.
The October 5, 2026 business update points to double-digit revenue growth and mid-twenties operating profit growth for Q2FY27, with management saying it is likely to surpass near-term guidance across key financial parameters. The FY27 framework targets double-digit revenue growth crossing Rs. 15,000 Cr and high-teen EBITDA growth with a 20% aspiration.
Revenue rose 23% YoY to Rs. 3,957 Cr, with India volume growth of 11% — the highest in 20 quarters — and EBITDA and PAT both up 25%, the highest in 28 quarters. Gross margin improved 30 bps YoY on softening copra prices and favourable portfolio mix, while A&P investment rose 25% YoY.